AD Ports Logistics (ADPL), a subsidiary of AD Ports Group, and Acino, a Swiss pharmaceutical company, have agreed to have ADPL provide worldwide freight forwarding services to Acino.
This freight forwarding service is reportedly inclusive of sea and air transport in the Middle East and North Africa (MENA) region.
ADPL aims to use its fully integrated and GDP-certified end-to-end pharma cold chain capabilities to carry important drugs from Acino’s worldwide sites of origin to markets in the MENA area under the terms of the deal.
ADPL’s Healthcare & Lifesciences business will be required to provide specific transport and handling capabilities for pharmaceutical items.
The scope of the goods forwarding services will comprise first-mile transport, ports and airport loading, customs clearance, and final-mile logistics, according to the conditions of the agreement.
Farook Al Zeer, Chairman, Logistics Cluster, AD Ports Group, said: “We are delighted to have been selected by our partners at Acino as a pharma logistics provider.
“The agreement is a significant development opportunity for our Healthcare & Lifesciences division as it allows us to work with a leading global pharmaceutical manufacturer and showcase our capabilities as an enabler of global trade and logistics.”
Andrew Bird, Interim CEO, Acino, stated: “Our collaboration with AD Ports Group strengthens our commitment to the MENA region, expanding outreach and improving patient access to quality healthcare.”
Mario Ricard, Chief Operations Officer, Acino, added: “We are pleased to enter into partnership with AD Ports Group that is set to enhance the speed and efficiency of delivering vital medications to the MENA region and beyond.
“Together, we reshape healthcare delivery, paving the way for an innovative and patient-centric industry landscape.”